Creative Medical Technology (CELZ) Competitors $2.63 +0.08 (+3.14%) (As of 02:35 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CELZ vs. CGTX, NNVC, BFRG, ENLV, FLGC, MRNS, BGXX, CARA, TENX, and SYBXShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Cognition Therapeutics (CGTX), NanoViricides (NNVC), Bullfrog AI (BFRG), Enlivex Therapeutics (ENLV), Flora Growth (FLGC), Marinus Pharmaceuticals (MRNS), Bright Green (BGXX), Cara Therapeutics (CARA), Tenax Therapeutics (TENX), and Synlogic (SYBX). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Cognition Therapeutics NanoViricides Bullfrog AI Enlivex Therapeutics Flora Growth Marinus Pharmaceuticals Bright Green Cara Therapeutics Tenax Therapeutics Synlogic Creative Medical Technology (NASDAQ:CELZ) and Cognition Therapeutics (NASDAQ:CGTX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, community ranking, risk, earnings, profitability, analyst recommendations and valuation. Is CELZ or CGTX more profitable? Creative Medical Technology's return on equity of -63.05% beat Cognition Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -63.05% -60.42% Cognition Therapeutics N/A -150.93%-100.82% Does the media prefer CELZ or CGTX? In the previous week, Creative Medical Technology had 6 more articles in the media than Cognition Therapeutics. MarketBeat recorded 9 mentions for Creative Medical Technology and 3 mentions for Cognition Therapeutics. Creative Medical Technology's average media sentiment score of 1.07 beat Cognition Therapeutics' score of -0.31 indicating that Creative Medical Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Creative Medical Technology 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cognition Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in CELZ or CGTX? Creative Medical Technology received 55 more outperform votes than Cognition Therapeutics when rated by MarketBeat users. Likewise, 68.93% of users gave Creative Medical Technology an outperform vote while only 64.00% of users gave Cognition Therapeutics an outperform vote. CompanyUnderperformOutperformCreative Medical TechnologyOutperform Votes7168.93% Underperform Votes3231.07% Cognition TherapeuticsOutperform Votes1664.00% Underperform Votes936.00% Which has preferable earnings & valuation, CELZ or CGTX? Creative Medical Technology has higher revenue and earnings than Cognition Therapeutics. Creative Medical Technology is trading at a lower price-to-earnings ratio than Cognition Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$10K460.25-$5.29M-$3.80-0.69Cognition TherapeuticsN/AN/A-$25.79M-$0.97-0.45 Do analysts recommend CELZ or CGTX? Cognition Therapeutics has a consensus target price of $8.00, suggesting a potential upside of 1,718.18%. Given Cognition Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Cognition Therapeutics is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creative Medical Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cognition Therapeutics 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more volatility and risk, CELZ or CGTX? Creative Medical Technology has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. Comparatively, Cognition Therapeutics has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Do institutionals & insiders hold more shares of CELZ or CGTX? 1.4% of Creative Medical Technology shares are owned by institutional investors. Comparatively, 43.4% of Cognition Therapeutics shares are owned by institutional investors. 2.8% of Creative Medical Technology shares are owned by company insiders. Comparatively, 20.8% of Cognition Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryCreative Medical Technology beats Cognition Therapeutics on 9 of the 16 factors compared between the two stocks. Ad Brownstone ResearchMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.60M$2.97B$5.10B$8.84BDividend YieldN/A1.91%5.04%4.07%P/E Ratio-0.6919.5495.6214.26Price / Sales460.25283.311,217.1987.73Price / CashN/A169.3839.5936.27Price / Book0.704.356.946.36Net Income-$5.29M-$41.63M$118.89M$225.56M7 Day Performance-1.13%-4.44%-1.33%-0.10%1 Month Performance-41.56%-6.01%-3.17%2.02%1 Year Performance-38.41%26.52%32.49%27.87% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology1.7302 of 5 stars$2.63+3.1%N/A-41.6%$4.60M$10,000.00-0.695Analyst RevisionPositive NewsCGTXCognition Therapeutics2.5728 of 5 stars$0.44flat$8.00+1,718.2%-57.7%$18.28MN/A-0.4520NNVCNanoViricidesN/A$1.30-2.3%N/A+15.8%$18.13MN/A-1.7420Analyst DowngradeBFRGBullfrog AIN/A$2.06+2.0%N/A-36.3%$17.94M$60,000.000.004Gap UpENLVEnlivex Therapeutics3.075 of 5 stars$0.83-14.9%$6.00+622.8%-42.9%$17.77MN/A-0.7170News CoverageGap UpHigh Trading VolumeFLGCFlora Growth2.2015 of 5 stars$1.30+6.8%$6.00+360.7%+22.0%$17.41M$76.07M0.00280Analyst RevisionNews CoverageMRNSMarinus Pharmaceuticals4.4503 of 5 stars$0.31+0.7%$4.79+1,437.8%-95.0%$17.18M$30.99M-0.13110Analyst ForecastAnalyst RevisionGap DownBGXXBright GreenN/A$0.09+5.4%N/A-78.4%$17.15MN/A-1.422News CoverageGap DownCARACara Therapeutics3.7192 of 5 stars$0.31+0.8%$2.32+654.5%-71.2%$16.87M$20.97M-0.1855Analyst ForecastTENXTenax Therapeutics2.7706 of 5 stars$4.88+2.3%$16.00+227.9%-83.5%$16.64MN/A0.009Analyst RevisionNews CoveragePositive NewsSYBXSynlogic2.7524 of 5 stars$1.39-3.8%$30.00+2,058.3%-30.5%$16.26M$3.37M-0.356Positive News Related Companies and Tools Related Companies Cognition Therapeutics Alternatives NanoViricides Alternatives Bullfrog AI Alternatives Enlivex Therapeutics Alternatives Flora Growth Alternatives Marinus Pharmaceuticals Alternatives Bright Green Alternatives Cara Therapeutics Alternatives Tenax Therapeutics Alternatives Synlogic Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CELZ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
